These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32558957)

  • 1. Subversion of host stress granules by coronaviruses: Potential roles of π-rich disordered domains of viral nucleocapsids.
    Moosa MM; Banerjee PR
    J Med Virol; 2020 Dec; 92(12):2891-2893. PubMed ID: 32558957
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs.
    Perdikari TM; Murthy AC; Ryan VH; Watters S; Naik MT; Fawzi NL
    EMBO J; 2020 Dec; 39(24):e106478. PubMed ID: 33200826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.
    Cai T; Yu Z; Wang Z; Liang C; Richard S
    J Biol Chem; 2021 Jul; 297(1):100821. PubMed ID: 34029587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates.
    Savastano A; Ibáñez de Opakua A; Rankovic M; Zweckstetter M
    Nat Commun; 2020 Nov; 11(1):6041. PubMed ID: 33247108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
    Wang R; Simoneau CR; Kulsuptrakul J; Bouhaddou M; Travisano KA; Hayashi JM; Carlson-Stevermer J; Zengel JR; Richards CM; Fozouni P; Oki J; Rodriguez L; Joehnk B; Walcott K; Holden K; Sil A; Carette JE; Krogan NJ; Ott M; Puschnik AS
    Cell; 2021 Jan; 184(1):106-119.e14. PubMed ID: 33333024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.
    Obajuluwa AO; Okiki PA; Obajuluwa TM; Afolabi OB
    Pan Afr Med J; 2020; 37():285. PubMed ID: 33654512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
    Fung TS; Liu DX
    Annu Rev Microbiol; 2021 Oct; 75():19-47. PubMed ID: 33492978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
    Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
    EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage.
    Ma J; Zhu F; Zhao M; Shao F; Yu D; Ma J; Zhang X; Li W; Qian Y; Zhang Y; Jiang D; Wang S; Xia P
    EMBO J; 2021 Sep; 40(18):e108249. PubMed ID: 34296442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.
    Sangith N
    Med Hypotheses; 2020 Nov; 144():110030. PubMed ID: 32758876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load.
    Mourier T; Shuaib M; Hala S; Mfarrej S; Alofi F; Naeem R; Alsomali A; Jorgensen D; Subudhi AK; Ben Rached F; Guan Q; Salunke RP; Ooi A; Esau L; Douvropoulou O; Nugmanova R; Perumal S; Zhang H; Rajan I; Al-Omari A; Salih S; Shamsan A; Al Mutair A; Taha J; Alahmadi A; Khotani N; Alhamss A; Mahmoud A; Alquthami K; Dageeg A; Khogeer A; Hashem AM; Moraga P; Volz E; Almontashiri N; Pain A
    Nat Commun; 2022 Feb; 13(1):601. PubMed ID: 35105893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immune Responses against Coronavirus Infections: Friend or Foe?
    Vafaeinezhad A; Atashzar MR; Baharlou R
    Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variation and Evolution of the 2019 Novel Coronavirus.
    Dimonte S; Babakir-Mina M; Hama-Soor T; Ali S
    Public Health Genomics; 2021; 24(1-2):54-66. PubMed ID: 33406522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diversity of coronavirus host cell entry receptors.
    Millet JK; Jaimes JA; Whittaker GR
    FEMS Microbiol Rev; 2021 May; 45(3):. PubMed ID: 33118022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit stress granule formation.
    Dolliver SM; Kleer M; Bui-Marinos MP; Ying S; Corcoran JA; Khaperskyy DA
    PLoS Pathog; 2022 Dec; 18(12):e1011041. PubMed ID: 36534661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.
    Aguilar-Bretones M; Westerhuis BM; Raadsen MP; de Bruin E; Chandler FD; Okba NM; Haagmans BL; Langerak T; Endeman H; van den Akker JP; Gommers DA; van Gorp EC; GeurtsvanKessel CH; de Vries RD; Fouchier RA; Rockx BH; Koopmans MP; van Nierop GP
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34499051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.